Using nuclear magnetic resonance urine metabolomics to develop a prediction model of early stages of renal disease in subjects with type 2 diabetes.
Lucio-Gutiérrez JR, Cordero-Pérez P, Farías-Navarro IC, Tijerina-Marquez R, Sánchez-Martínez C, Ávila-Velázquez JL, García-Hernández PA, Náñez-Terreros H, Coello-Bonilla J, Pérez-Trujillo M, Parella T, Torres-González L, Waksman-Minsky NH, Saucedo AL.
Lucio-Gutiérrez JR, et al. Among authors: perez trujillo m.
J Pharm Biomed Anal. 2022 Sep 20;219:114885. doi: 10.1016/j.jpba.2022.114885. Epub 2022 Jun 18.
J Pharm Biomed Anal. 2022.
PMID: 35779355